The Urokinase Plasminogen Activator Receptor (UPAR) Is Preferentially Induced by Nerve Growth Factor in PC12 Pheochromocytoma Cells and Is Required for NGF-Driven Differentiation

Nerve growth factor (NGF)-driven differentiation of PC12 pheo-chromocytoma cells is a well studied model used both to identify molecular, biochemical, and physiological correlates of neurotrophin-driven neuronal differentiation and to determine the causal nature of specific events in this differentiation process. Although epidermal growth factor (EGF) elicits many of the same early biochemical and molecular changes in PC12 cells observed in response to NGF, EGF does not induce molecular or morphological differentiation of PC12 cells. The identification of genes whose expression is differentially regulated by NGF versus EGF in PC12 cells has, therefore, been considered a source of potential insight into the molecular specificity of neurotrophin-driven neuronal differentiation. A " second generation " representational difference analysis procedure now identifies the urokinase plasminogen activator receptor (UPAR) as a gene that is much more extensively induced by NGF than by EGF in PC12 cells. Both an antisense oligonucleotide for the UPAR mRNA and an antibody directed against UPAR protein block NGF-induced morphological and biochemical differentiation of PC12 cells; NGF-induced UPAR expression is required for subsequent NGF-driven differentiation. In the PC12 pheochromocytoma cell model system, nerve growth factor (NGF) acts as a neurogenic agent, inducing a differentiation program. In contrast, epidermal growth factor (EGF) acts as NGF and EGF both rapidly induce the transcription of primary response or immediate-early genes, genes whose transcription requires only the activation of preexisting signaling molecules and transcription factors (Hersch-man, 1991). We showed previously that representational difference analysis (RDA) (Lisitsyn et al., 1993) is an effective way to clone genes that are differentially induced by NGF versus EGF in PC12 cells (Vician et al., 1997). One advantage of RDA is that it can be iterated; cDNAs for genes known to be preferentially expressed in a given cell population can be added to the " driver " cDNA population, and RDA can be repeated. The previously identified genes enriched in the " tester " cDNA population should be eliminated, and additional amplicons that are elevated in the tester versus driver population should be enriched in the reiterated RDA procedure. We have used a " second generation " RDA procedure to identify additional genes that are preferentially induced in NGF-versus EGF-treated PC12 cells. One of the genes identified in this iterated RDA analysis of NGF-driven neuronal differentiation is the urokinase plasminogen activator receptor (UPAR). UPAR is a glycosyl-phosphatidylinositol (GPI)-linked membrane protein lacking transmembrane and cytosolic domains (Ploug et al., 1991; Wang …

[1]  A. Villa,et al.  Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. , 1999, Blood.

[2]  M. Rosner,et al.  Protein Kinase Cδ Mediates Neurogenic but Not Mitogenic Activation of Mitogen-Activated Protein Kinase in Neuronal Cells , 1999, Molecular and Cellular Biology.

[3]  H. Chapman,et al.  A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling , 1999, The Journal of cell biology.

[4]  P. Lazarovici,et al.  Protein kinase C-epsilon plays a role in neurite outgrowth in response to epidermal growth factor and nerve growth factor in PC12 cells. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[5]  L. Mayne,et al.  Application of a Rapid Method (Targeted Display) for the Identification of Differentially Expressed mRNAs Following NGF-Induced Neuronal Differentiation in PC12 Cells , 1999, Molecular and Cellular Neuroscience.

[6]  E. Nishida,et al.  Requirement of p38 Mitogen-activated Protein Kinase for Neuronal Differentiation in PC12 Cells* , 1998, The Journal of Biological Chemistry.

[7]  D. Gurwitz,et al.  NGF induces transient but not sustained activation of ERK in PC12 mutant cells incapable of differentiating , 1998, Journal of cellular biochemistry.

[8]  M. Baudry,et al.  Seizure activity induces PIM‐1 expression in brain , 1998, Journal of neuroscience research.

[9]  D. Alessi,et al.  Mitogen‐ and stress‐activated protein kinase‐1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB , 1998, The EMBO journal.

[10]  M. Baudry,et al.  KID-1, a Protein Kinase Induced by Depolarization in Brain* , 1998, The Journal of Biological Chemistry.

[11]  F. Hucho,et al.  Downstream targets of urokinase-type plasminogen-activator-mediated signal transduction. , 1998, European journal of biochemistry.

[12]  S. Agrawal,et al.  Mixed backbone oligonucleotides: improvement in oligonucleotide-induced toxicity in vivo. , 1998, Antisense & nucleic acid drug development.

[13]  R. Medcalf,et al.  The urokinase-type-plasminogen-activator receptor (CD87) is a pleiotropic molecule. , 1998, European journal of biochemistry.

[14]  S. Thorgeirsson,et al.  Modulation of the plasminogen activator/plasmin system in rat liver regenerating by recruitment of oval cells. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[15]  P. Hufnagl,et al.  Urokinase Receptor Is Associated with the Components of the JAK1/STAT1 Signaling Pathway and Leads to Activation of This Pathway upon Receptor Clustering in the Human Kidney Epithelial Tumor Cell Line TCL-598* , 1997, The Journal of Biological Chemistry.

[16]  M. Greenberg,et al.  Neurotrophin Regulation of Gene Expression , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[17]  Steven Finkbeiner,et al.  CREB: A Major Mediator of Neuronal Neurotrophin Responses , 1997, Neuron.

[18]  H. Herschman,et al.  Identification of genes preferentially induced by nerve growth factor versus epidermal growth factor in PC12 pheochromocytoma cells by means of representational difference analysis , 1997, Journal of neuroscience research.

[19]  D. A. Bulseco,et al.  A Novel, Nerve Growth Factor-activated Pathway Involving Nitric Oxide, p53, and p21WAF1 Regulates Neuronal Differentiation of PC12 Cells* , 1997, The Journal of Biological Chemistry.

[20]  R. Caldini,et al.  Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters. , 1997, Biochemistry.

[21]  E. Korzus,et al.  The Mitogen-activated Protein Kinase and JAK-STAT Signaling Pathways Are Required for an Oncostatin M-responsive Element-mediated Activation of Matrix Metalloproteinase 1 Gene Expression* , 1997, The Journal of Biological Chemistry.

[22]  Michael V. Doyle,et al.  Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.

[23]  Mamoru Sano,et al.  Re-examination of the local control by nerve growth factor of the outgrowth of neurites in PC12D cells , 1996, Brain Research.

[24]  S. Rabbani,et al.  Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis , 1996, International journal of cancer.

[25]  R. Bradshaw,et al.  Induction of Neurite Outgrowth by Interleukin-6 Is Accompanied by Activation of Stat3 Signaling Pathway in a Variant PC12 Cell (E2) Line* , 1996, The Journal of Biological Chemistry.

[26]  M. Gyetko,et al.  The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. , 1996, The Journal of clinical investigation.

[27]  F. Blasi,et al.  Proteolytic cleavage of the urokinase receptor substitutes for the agonist‐induced chemotactic effect. , 1996, The EMBO journal.

[28]  N. Seeds,et al.  Modulated expression of plasminogen activator system components in cultured cells from dissociated mouse dorsal root ganglia , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  P. Carmeliet,et al.  Generation and characterization of urokinase receptor-deficient mice. , 1996, The Journal of clinical investigation.

[30]  Grigori Enikolopov,et al.  Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells , 1995, Nature.

[31]  L. Matrisian,et al.  A Novel Nerve Growth Factor-responsive Element in the Stromelysin-1 (Transin) Gene That Is Necessary and Sufficient for Gene Expression in PC12 Cells (*) , 1995, The Journal of Biological Chemistry.

[32]  M. Greenberg,et al.  Serine 133-Phosphorylated CREB Induces Transcription via a Cooperative Mechanism That May Confer Specificity to Neurotrophin Signals , 1995, Molecular and Cellular Neuroscience.

[33]  P. Brehm,et al.  A single pulse of nerve growth factor triggers long-term neuronal excitability through sodium channel gene induction , 1995, Neuron.

[34]  H. Petty,et al.  Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium. , 1995, Journal of immunology.

[35]  S. Waxman,et al.  Induction of cell migration by pro-urokinase binding to its receptor: possible mechanism for signal transduction in human epithelial cells , 1994, The Journal of cell biology.

[36]  M. Gyetko,et al.  The urokinase receptor is required for human monocyte chemotaxis in vitro. , 1994, The Journal of clinical investigation.

[37]  S. Rabbani,et al.  Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts , 1994, FEBS letters.

[38]  S. Clarke,et al.  Early responses of PC‐12 cells to NGF and EGF: Effect of K252a and 5′‐methylthioadenosine on gene expression and membrane protein methylation , 1993, Journal of neuroscience research.

[39]  J. Wagner,et al.  Nerve growth factor induces transcription of NGFIA through complex regulatory elements that are also sensitive to serum and phorbol 12-myristate 13-acetate. , 1993, Molecular endocrinology.

[40]  M. Wigler,et al.  Cloning the differences between two complex genomes , 1993, Science.

[41]  M. Ruggiero,et al.  Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells. , 1993, Biochemical and biophysical research communications.

[42]  M. Chao Neurotrophin receptors: A window into neuronal differentiation , 1992, Neuron.

[43]  K. Danø,et al.  Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. , 1991, The Journal of biological chemistry.

[44]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[45]  E. Appella,et al.  Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. , 1990, The EMBO journal.

[46]  B. Paterson,et al.  A protein induced by NGF in PC12 cells is stored in secretory vesicles and released through the regulated pathway. , 1989, The EMBO journal.

[47]  J. de Vellis,et al.  Tis gene expression in cultured rat astrocytes: Multiple pathways of induction by mitogens , 1989, Journal of neuroscience research.

[48]  L. Matrisian,et al.  NGF induction of the gene encoding the protease transin accompanies neuronal differentiation in PC12 cells , 1989, Neuron.

[49]  G. Guroff,et al.  Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor , 1981, The Journal of cell biology.

[50]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Walker,et al.  Antisense Therapeutics , 2005, Methods in Molecular Medicine™.

[52]  B. Deurs,et al.  Urokinase-type plasminogen activator receptor is internalized by different mechanisms in polarized and nonpolarized Madin-Darby canine kidney epithelial cells. , 1999, Molecular biology of the cell.

[53]  S. Rabbani Metalloproteases and urokinase in angiogenesis and tumor progression. , 1998, In vivo.

[54]  J. D. Pollock,et al.  EGF in combination with depolarization or cAMP produces morphological but not physiological differentiation in PC12 cells , 1997, Journal of neuroscience research.

[55]  H. Friess,et al.  Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. , 1997, British Journal of Cancer.

[56]  W. Doe,et al.  Structure of the human urokinase receptor gene and its similarity to CD59 and the Ly-6 family. , 1995, European journal of biochemistry.

[57]  H. Herschman Primary response genes induced by growth factors and tumor promoters. , 1991, Annual review of biochemistry.